OFFIMED
ActiveSummary
OFFIMED has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €539,780 and a net result of €38,722. Equity is growing by about 22% per year across the filed financial years. Its solvency ranks better than 53% of 3,369 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
- Staff
- 10.3 FTE
- Equity
- €539,780
- Profit
- €38,722
- Parent
- CABINET GEMBLOUTOIS DE MEDECINE GENERALE D.N. · 100%
- Board
- 10 members
Why 95raises riskSize: 10.3 FTE, total assets €1.1mlowers riskLiquidity: current ratio 1.56, cash €499,797Equity €539,780 (50.5% of total assets)Sector: Computer programming, consultancy and related activities (NACE 62)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 62, small): better than 63% on solvency, 87% on liquidity, 59% on profitability and 29% on growth.
The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 11 days after the deadline; the sector median (NACE 62) for financial year 2024 is 9 days before the deadline, and 33% of those companies filed late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · abbreviated…
- Appointment: Jean-Christophe Alsteens (director)Resignation: Charles Ronlez (director)
- Annual accounts filedfinancial year 2024 · full…
Financials · financial year 2025, abbreviated format
2025 annual accounts filed late (10 days) Filed on 10 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00390530.
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result recovers in 2025; 2025 is 55% above 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Average staff in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 62, Computer programming, consultancy and related activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Peer companies
Historical observationOf the 6,049 companies that looked in July 2024 the way this one looks now, 0.4% went bankrupt within 24 months and 95.9% are still going.
- Small
- 10 to 20 years old
- solvency 30% or more
- a profit under 5% of the balance sheet
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,474 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,049 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | - | €373,647 | €422,961 | €474,613 | €548,865 | €727,920 | ▲ 32.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €29,298 | €53,172 | €55,389 | €82,628 | €117,177 | €146,629 | €153,886 | €174,683 | ▲ 13.5% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | - | - | - | - | €5,963 | - |
| Other operating charges640/8 | - | - | - | €622 | €622 | €676 | €848 | €1,312 | ▲ 54.7% |
| Gross operating margin9900 | €258,297 | €401,324 | €503,146 | €615,995 | €717,560 | €670,369 | €740,351 | €966,752 | ▲ 30.6% |
| Operating profit (loss)9901 | -€66,220 | €17,623 | €136,001 | €159,097 | €176,800 | €48,450 | €36,752 | €56,874 | ▲ 54.8% |
| Financial income75/76B | - | - | - | €111 | - | €314 | €2,488 | €4,053 | ▲ 62.9% |
| Recurring financial income75 | €129 | €314 | €86 | €111 | - | €314 | €2,488 | €4,053 | ▲ 62.9% |
| Financial charges65/66B | - | - | - | €209 | €389 | €140 | €601 | €319 | ▼ 47.0% |
| Recurring financial charges65 | €383 | €87 | €76 | €209 | €389 | €140 | €601 | €319 | ▼ 47.0% |
| Profit (loss) for the period before taxes9903 | -€66,473 | €17,850 | €136,011 | €158,999 | €176,411 | €48,624 | €38,639 | €60,608 | ▲ 56.9% |
| Income taxes67/77 | €248 | €183 | €299 | €21,317 | €37,655 | €14,533 | €13,303 | €21,887 | ▲ 64.5% |
| Profit (loss) for the period9904 | -€66,721 | €17,667 | €135,713 | €137,682 | €138,756 | €34,091 | €25,336 | €38,722 | ▲ 52.8% |
| Profit (loss) for the period to be appropriated9905 | -€66,721 | €17,667 | €135,713 | €137,682 | €138,756 | €34,091 | €25,336 | €38,722 | ▲ 52.8% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €0.4m | €0.4m | €0.6m | €0.6m | €0.8m | €0.9m | €0.9m | €1.1m | ▲ 21.2% |
| Fixed assets21/28 | €0.1m | €0.2m | €0.3m | €0.2m | €0.3m | €0.2m | €0.2m | €0.2m | ▲ 10.3% |
| Intangible fixed assets21 | €0.09m | €0.2m | €0.3m | €0.2m | €0.3m | €0.2m | €0.2m | €0.2m | ▲ 12.6% |
| Tangible fixed assets22/27 | €0.006m | €0.008m | €0.003m | €0.001m | €0.006m | €0.005m | €0.008m | €0.004m | ▼ 50.2% |
| Furniture and vehicles24 | - | - | - | €0.001m | €0.006m | €0.005m | €0.008m | €0.004m | ▼ 50.2% |
| Financial fixed assets28 | - | - | - | - | €250 | €250 | €0 | - | - |
| Current assets29/58 | €0.3m | €0.2m | €0.3m | €0.4m | €0.5m | €0.6m | €0.7m | €0.8m | ▲ 24.9% |
| Stocks and contracts in progress3 | €0.006m | €0.01m | €0.006m | €0.005m | €0.004m | €0.004m | €0.003m | €0.003m | ▼ 12.0% |
| Stocks30/36 | - | - | - | €0.005m | €0.004m | €0.004m | €0.003m | €0.003m | ▼ 12.0% |
| Amounts receivable within one year40/41 | €0.09m | €0.1m | €0.09m | €0.08m | €0.1m | €0.2m | €0.3m | €0.3m | ▲ 23.8% |
| Trade receivables40 | - | - | - | €0.08m | €0.1m | €0.2m | €0.2m | €0.3m | ▲ 39.6% |
| Other amounts receivable41 | - | - | - | - | €209 | €0.02m | €0.03m | €0.008m | ▼ 76.8% |
| Cash at bank and in hand54/58 | €0.2m | €0.1m | €0.2m | €0.3m | €0.4m | €0.5m | €0.4m | €0.5m | ▲ 28.8% |
| Deferred charges and accrued income490/1 | - | - | - | - | - | €0.002m | €0.02m | €0.01m | ▼ 39.8% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €0.4m | €0.4m | €0.6m | €0.6m | €0.8m | €0.9m | €0.9m | €1.1m | ▲ 21.2% |
| Equity10/15 | €0.2m | €0.2m | €0.3m | €0.4m | €0.5m | €0.5m | €0.5m | €0.5m | ▼ 1.6% |
| Contributions10/11 | €0.4m | €0.4m | - | €0.4m | €0.4m | €0.4m | €0.4m | €0.4m | ▼ 2.8% |
| Reserves13 | - | - | - | - | €0.002m | €0.002m | €0 | - | - |
| Tax-exempt reserves132 | - | - | - | - | €0.002m | €0.002m | €0 | - | - |
| Profit (loss) carried forward14 | -€0.3m | -€0.3m | -€0.1m | €0.01m | €0.1m | €0.1m | €0.1m | €0.1m | ▲ 3.5% |
| Amounts payable17/49 | €0.2m | €0.2m | €0.3m | €0.2m | €0.3m | €0.3m | €0.3m | €0.5m | ▲ 58.8% |
| Amounts payable within one year42/48 | €0.2m | €0.2m | €0.3m | €0.2m | €0.3m | €0.3m | €0.3m | €0.5m | ▲ 58.8% |
| Trade debts44 | €0.1m | €0.2m | €0.2m | €0.08m | €0.2m | €0.1m | €0.2m | €0.3m | ▲ 64.7% |
| Suppliers440/4 | - | - | - | €0.08m | €0.2m | €0.1m | €0.2m | €0.3m | ▲ 64.7% |
| Taxes, remuneration and social security45 | - | - | - | €0.09m | €0.07m | €0.2m | €0.09m | €0.1m | ▲ 63.7% |
| Taxes450/3 | - | - | - | €0.04m | €0.02m | €0.04m | €0.01m | €0.05m | ▲ 259% |
| Remuneration and social security454/9 | - | - | - | €0.05m | €0.05m | €0.1m | €0.07m | €0.09m | ▲ 25.3% |
| Other amounts payable47/48 | - | - | - | - | €0.03m | €0.04m | €0.03m | €0.03m | ▲ 7.4% |
| Accrued charges and deferred income492/3 | - | - | - | €0.004m | €0.002m | - | - | - | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€66,721 | €17,667 | €135,713 | €137,682 | €138,756 | €34,091 | €25,336 | €38,722 | ▲ 52.8% |
| + Depreciation and write-downs630 | €29,298 | €53,172 | €55,389 | €82,628 | €117,177 | €146,629 | €153,886 | €174,683 | ▲ 13.5% |
| Operating cash flow (approximation) | -€37,424 | €70,839 | €191,102 | €220,310 | €255,934 | €180,720 | €179,221 | €213,405 | ▲ 19.1% |
| Investment in fixed assets (approximation) | - | -€130,340 | -€136,542 | -€62,718 | -€174,854 | -€95,748 | -€129,323 | -€197,443 | ▼ 52.7% |
| Change in cash | - | -€56,159 | €74,791 | €63,527 | €108,320 | €74,930 | -€65,195 | €111,860 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 11 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | abbreviated format | 10-08-2026 | 2026-00390530 |
| 31-12-2024 | full format | 20-08-2025 | 2025-00386284 |
| 31-12-2023 | full format | 19-08-2024 | 2024-00353434 |
| 31-12-2022 | full format | 11-07-2023 | 2023-00229976 |
| 31-12-2021 | micro format | 23-06-2022 | 2022-20091304 |
| 31-12-2020 | micro format | 19-08-2021 | 2021-50500487 |
| 31-12-2019 | full format | 05-10-2020 | 2020-59000532 |
| 31-12-2018 | full format | 22-07-2019 | 2019-36100145 |
| 31-12-2017 | micro format | 28-05-2018 | 2018-14700191 |
| 31-12-2016 | full format | 23-06-2017 | 2017-21300526 |
Similar companies · same sector, comparable size
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Board 10
Show all 10 directors
Permanent representatives 2
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| ARJO |
|
| BRW conseil |
|
| Hugues Lambion |
|
| LOUSBERG Jean-Luc |
|
| MILAZZO Santo |
|
| Moens Carl |
|
| NOTTE Dominique |
|
| PIGNON Julien |
|
| TENRET Didier |
|
| Jean-Christophe Alsteens |
|
| Charles Ronlez |
|
| KOHL Michel |
|
| VAN DER MAREN Francis |
|
Owners and capital
Owners
2 ownersChain of control
Highest known parent: CABINET GEMBLOUTOIS DE MEDECINE GENERALE D.N.. The sources do not say who stands above it.
Owners 2
- 100%
-
0.01%
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Group and network
Connections & network
5 connected companiesShow 1 more companies with a shared director
History
Acts, filings and financial milestones
21-08
Gazette deed
Appointment: Jean-Christophe Alsteens (director)Resignation: Charles Ronlez (director)4 facts ▸
- General meeting, 19-06-2025
- Director appointment, Jean-Christophe Alsteens (director)
- Director resignation, Charles Ronlez (director)
- Director in office, Bruno Willems (managing director)
03-04
Gazette deed
Amendment of the articles · Legal-form change · Resignations & appointmentsResignations: KOHL Michel, VAN DER MAREN Francis and BRW conseil · Appointments: MOËNS Carl Jean Gaston Jules Ghislain, LAMBION Hugues Yves Auguste Ernest Julien and 8 others · Permanent representatives: VAN SCHIL Dirk and WILLEMS Bruno28 facts ▸
- General meeting, 21-03-2024
- Incorporation, 03-04-2014
- Other provision, “statuts non modifiés depuis constitution” (deed in French)
- Amendment of the articles (2 times)
- Purpose change
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French) (2 times)
- Kind of shares, “unanimité des voix, redéfinition des droits attachés aux classes de parts” (deed in French)
- Kind of shares, 3, EUR
- Registered office clause, “5000 Namur, rue des Dames Blanches”, 1, “boîte B, dispositions transitoires” (deed in French)
- Director resignation, KOHL Michel (director)
- Director resignation, VAN DER MAREN Francis (director)
- Director resignation, BRW conseil (director)
- +16 further facts in this act
Show earlier events
About the unread acts
Of the 6 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 24 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 92094C0168/00V000 | Wallonia | 979 m² | 1 · 351 m² | - |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Le développement, la commercialisation, la livraison et l’entretien de produits, services et études destinés aux professionnels de la santé…” (deed in French)
4 activities (deed in French)
- Le développement, la commercialisation, la livraison et l’entretien de produits, services et études destinés aux professionnels de la santé, notamment de produits et services dans le domaine informatique.
- Le développement, la commercialisation, la livraison, et l’entretien de programmes, services, et matériel informatique et autres en lien avec la tarification, la facturation des médicaments, les prestations médicales ou pharmaceutiques, ou en connection avec ces domaines.
- Le conseil et l’assistance des professionnels de la santé, dans les domaines d’activité de la société.
- La mise en commun des outils, ressources, compétences, en vue de soutenir directement ou indirectement ces objectifs.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- OFFIMED
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région wallonne, simple décision organe d’administration” (deed in French)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “• confier la direction de tout ou partie des affaires sociales à un ou plusieurs directeurs, ayant ou non la qualité d'administrateur ; •…”
- Board ruleHow the board is made up, meets and takes decisions.
- “Coopérateurs de classe à assemblée générale, 7” (deed in French)“Conseil établit Règlement et sollicite approbation assemblée le cas échéant, plus étendus prévus par loi tous actes nécessaires ou utiles…” (deed in French)4 more provisions on this in the deed
Capital, shares and profit
- Share issue ruleHow and by whom new shares can be issued.
- “Organe d'administration peut émettre nouvelles parts dans classes existantes aux conditions qu'il détermine, 1% totalité parts émises toutes…” (deed in French)
- Financial instrumentSecurities other than shares, such as bonds or warrants, the company can issue.
- One provision in the deed
- Membership ruleWho can become a member or partner, and on what terms.
- One provision in the deed
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Second Tuesday of June at 15:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Liquidateurs, dissolution pour quelque cause que ce soit” (deed in French)